BioModelsapplication/xmlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.pdfhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000-biopax2.owlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000-biopax3.owlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000_urn.xmlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000_url.xmlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.vcmlhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.scihttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.mhttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.pnghttps://www.ebi.ac.uk/biomodels/model/download/MODEL1112110000?filename=MODEL1112110000.xppprimaryOK200Ishan AjmeraNon-curatedordinary differential equation modelDiabetes MellitusL2V4https://www.ebi.ac.uk/biomodels/MODEL1112110000falseBioModelsSBMLModelsAlvehag2006 IVGTT GlucoseModel A2008MODEL1112110000Alvehag, K.; Martin, C.Alvehag10.1109/CDC.2006.377192,
This paper develops a mathematical model for the feedback control of glucose regulation in the healthy human being and is based on the work of Sorensen (1985). The proposed model serves as a starting point for modeling type II diabetes. Four agents - glucose and the three hormones insulin, glucagon, and incretins - are assumed to have an effect on glucose metabolism. By letting compartments represent anatomical organs, the model has a close resemblance to a real human body. Mass balance equations that account for blood flows, exchange between compartments, and metabolic sinks and sources are written, and these result in simultaneous differential equations that are solved numerically. The metabolic sinks and sources - removing or adding glucose, insulin, glucagon, and incretins - describe physiological processes in the body. These processes function as feedback control systems and have nonlinear behaviors. The results of simulations performed for three different clinical test types indicate that the model is successful in simulating intravenous glucose, oral glucose, and meals containing mainly carbohydrates. null, null.
nullajmera@ebi.ac.uk10.1109/CDC.2006.377192EMBL-EBIprojections, extent, Soluble, type 2, Public Sectors, GRPP, noninsulin-dependent diabetes mellitus, PNT-P1, Glukose, Mealtime, NetrinA, AUTSX5, L-histidyl-L-seryl-L-glutaminylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-tyrosyl-L-seryl-L-lysyl-L-tyrosyl-L-leucyl-L-alpha-aspartyl-L-seryl-L-arginyl-L-arginyl-L-alanyl-L-glutaminyl-L-alpha-aspartyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-leucyl-L-methionyl-L-asparaginyl-L-threonine, D430049E23Rik, insuline humaine, EY3-1, glucide, carbohydrates, Oxyntomodulin, glucido, Dextrose, 2, D-ets-2, 3520, Public Enterprise, WMS, Elkh, EK6, W, Sap-2, Body Parts and Fluids, NIDDM, endocrine, DmelCG4063, DIF, glucose, neuroendocrine tumour, Supper, Solute carrier family 6 member 2, TNFSF2, SLC6A5, TBL1, Tbl1, severe, NOVh, SGS, dif, insulinum humanum, tnfa, Glucagon, Elk, ELK, Regular, anatomical protrusion, completeness, His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr, Neuronally-expressed EPH-related tyrosine kinase, TNFA, GLP-1(7-37), saccharides, single organism process, SAP2, Receptor Agonists, Acceptance Processes, neuroendocrine neoplasm, Regular Insulin, ACMICD, insulin (recombinant), Norepinephrine transporter, Public Domain, shelf, Domains, GLP-1(7-36), Dinners, (alpha-D)-Isomer, Soluble Insulin, Glicentin-related polypeptide, glucose metabolism, Kohlenhydrat, D-Glucose, Plxn1, pntP2, Insulin-Releasing Hormone, Pointed-P1, whole organism, Ets94F, insulina humana, Meal Time, carbohidratos, projection, ridge, E-2f, mKIAA4053, human, E-2g, DmelCG6794, carbohidrato, DmelCG18657, Sector, non-insulin-dependent, Koerper, Tnfa, Feedbacks, Hyperglycemic-Glycogenolytic Factor, Glucose Monohydrate, hypertension, Incretin Effects, Incretin, AW488255, 0998/12, Incretin Effect, Sectors, multi-cellular organism, maturity-onset diabetes, Tb11, Glucose, Effects, lamellae, Processes, carbohydrate, number, saccharide, glucagonum, Copyrights, process of organ, noninsulin dependent diabetes, Hormone, Human, FBXW4, lamella, DMPOINT1A, Insulin, Cek6, Enterprises, noninsulin-dependent, portion of blood, Chain, Erp, APUDoma, ERP, pointed-RC, IGFBP9, Public Enterprises, man, Meal Times, EK3-2, l(3)07825, Glucose-Dependent, Insulin recombinant, His-ser-glu(nh2)-gly-thr-phe-thr-ser-asp-tyr-ser-lys-tyr-leu-asp-ser-arg-arg-ala-glu(NH2)-asp-phe-val-glu(NH2)-trp-leu-met-asp(NH2)-thr, Proglucagon (33-61), CG17077, Enterprise, laminae, Anhydrous, Net, NET, Ets, 6794, C130099E04Rik, whole blood, xtnf, body, anatomical process, whole body, function, SMAP55, neuroendocrine tumor, net, Dinner Times, Public, Insulin A Chain, MFS1, Sodium, Novolin, glucides, pnt-P1, pnt-P2, organ process, Incretin hormone, Human Figure, Body, HG-Factor, diabetes mellitis type 2, processes, Figures, EG:95B7.8, protection against, digenic, 2600013D04Rik, regulation, quantitative, netrin A, POINT, CG8705, Insulin B Chain, adult onset diabetes, single-organism process, DmelCG17077, Hyperglycemic Glycogenolytic Factor, Human Figures, Monohydrate, hydrates de carbone, Pnt, (DL)-Isomer, CCN3, QM, png, human insulin, animal, Effect, xtnf-alpha, fs(1)M104, Pnt-P1, type II diabetes mellitus, insulin, Kohlenhydrate, Dinnertime, reference sample, non-insulin dependent diabetes, Hormone Receptor, Public Domains, Parts, non-insulin dependent diabetes mellitus, CG6794, behavioral response to stimulus, type 2 diabetes mellitus, DL-glucose, IBP-9, insulin human, type 2 diabetes mellitus non-insulin dependent, physiological process, papilla, Figure, CT27014, Human Bodies, NET1, Body Parts, type 2 diabetes, netA, GPHYSD2, single-organism behavior, diabetes mellitis type II, biological process unknown, Papers, Process, Suppers, lamina, T2DM - type 2 diabetes mellitus, flanges, D-Ets-2, ets94F, Dinner, 0123/09, 9330129L11, late onset, results, organism, Acceptance Process, tnf-alpha, EPH-like kinase 6, NOV, Glucagon (1-29), PlexA1, Domain, saccharidum, Glucose Dependent Insulin Releasing Hormone, CG4063, Time, Glicentin, shelves, susceptibility to, nov, MASS, TNFalpha, hEK6, Glucagon-like peptide 2, insulin resistance, insulin resistance-related, Glucagon-like peptide 1, fs(1)Y[b], ptd, type II, PntP2, GLP-1, D Glucose, spine, PntP1, C130088N23Rik, type II diabetes, E(E2F)3D, PNTP2, glucidos, DXS648E, HSQGTFTSDYSKYLDSRRAQDFVQWLMNT, Physiological Processes, PNTP1, GLP-2, gluco-hexose, TNF-alpha, human being, Glucagon-like peptide 1(7-37), YB, Bodies, Dinnertimes, ETS2, Ets2, FBN, Insulin B, presence, protrusion, netrin, TNF-a, pntegfr, 0608/07, Yb, Hek6, Glucagon-like peptide 1(7-36), ECTOL1, Glukagon, non-insulin-dependent diabetes mellitus, Agonists, glucagon, CG2706, ENSMUSG00000074119, hormones, EBI, Ebi, Tyrosine-protein kinase receptor EPH-2, Hormone Receptor Agonists, ridges, adult-onset diabetes, OCTD, Iletin, biological_process, Abstract, 2.7.10.1, L10, Etrp, NAT1, Behaviors, association with, behaviour, l(3)j1B7, diabetes, Controlled, Controlling, OXM, (beta-D)-Isomer, vertebrate blood, DmelCG2706, OXY, EPH tyrosine kinase 2, DXS648, Carbohydrates, tnfsf2, Glucagone, count in organism, Sodium Insulin, IGFBP-9, Glucose-Dependent Insulin-Releasing, biological process, l(3)s118306, flange, WMS2, Data Base, HG Factor, Acceptance, Mealtimes, Exubera, Meal, diabetes mellitus, INS, cellular glucose metabolic process, Carbohydrate, CG18657, Anhydrous Dextrose, l(2)k16213, process, Ets58AB, presence or absence in organism., behavioural response to stimulus, EPHT2, Dinner Time, SSKS, processus, Times, Glucose-Dependent Insulin-Releasing Hormone, Tnfsf1a, GlcfalseAlvehag2006_IVGTT_GlucoseModel_A
This a model from the article:
The Feedback Control of Glucose: On the road to type II diabetes
Alvehag, K.; Martin, C. Proceedings of 45th IEEE Conference on Decision and Control
2006,685-690
Abstract:
This paper develops a mathematical model for the feedback control of glucose regulation in the healthy human being and is based on the work of Sorensen (1985). The proposed model serves as a starting point for modeling type II diabetes. Four agents - glucose and the three hormones insulin, glucagon, and incretins - are assumed to have an effect on glucose metabolism. By letting compartments represent anatomical organs, the model has a close resemblance to a real human body. Mass balance equations that account for blood flows, exchange between compartments, and metabolic sinks and sources are written, and these result in simultaneous dif- ferential equations that are solved numerically. The metabolic sinks and sources - removing or adding glucose, insulin, glucagon, and incretins - describe physiological processes in the body. These processes function as feedback control systems and have nonlinear behaviors. The results of simulations performed for three different clinical test types indicate that the model is successful in simulating intravenous glucose, oral glucose, and meals containing mainly carbohydrates.
This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2011 The BioModels.net Team.
To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication
for more information.
In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not..
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.
2011-12-112005-01-012011-12-11MODEL1112110000MODEL1112110000GO:0042593960610.1109/CDC.2006.377192